Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

On Friday, DexCom Inc (DXCM) stock saw a decline, ending the day at $80.24 which represents a decrease of $-0.33 or -0.41% from the prior close of $80.57. The stock opened at $80.03 and touched a low ...

Morgan Stanley has recently reduced ING Groep NV (ING) stock rating, as announced on November 26, 2024, according to Finviz. Earlier, on October 22, 2024, Barclays had reduced the stock from a ...

In the words of MicroStrategy co-founder Michael Saylor, 2024 was “year zero of institutional adoption.” Speaking of Saylor, ...

Morgan Stanley analyst Stephen Byrd suggested buying power companies he thought could benefit from the AI boom.

Experts say the playing field has fundamentally changed as fractional ownership and other paths to access make alternative ...

The Morgan Stanley executive is retiring to run a foundation she started that aims to bring more young women into wealth ...

For investors prioritizing long-term security and wealth preservation, gold stands as the clear choice, consistently ...

Wise Platform noted that during the past year, they've expanded their global payments network and made some upgrades to their ...

Stay cautious of market momentum in 2025. Stock picking will be key for value opportunities in overlooked sectors like real ...

In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...

Artificial intelligence (AI) was the dominant theme in the stock market in 2024. There were standout performances from select AI chip stocks, AI software stocks, and even energy stocks, as ...